KARIN FULLER: Open Payments
NPI 1225743495 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,521 in 108 payments from 17 companies in 2025. Trend: 2023 $1,339 · 2024 $1,844 · 2025 $2,521
Food & beverage: $2,521
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $488 |
| Regeneron Healthcare Solutions, Inc. | 13 | $441 |
| ABBVIE INC. | 22 | $420 |
| GENZYME CORPORATION | 7 | $231 |
| Novartis Pharmaceuticals Corporation | 10 | $174 |
| Galderma Laboratories, L.P. | 10 | $146 |
| E.R. Squibb & Sons, L.L.C. | 5 | $121 |
| LEO Pharma Inc. | 6 | $115 |
| Lilly USA, LLC | 4 | $114 |
| Amgen Inc. | 3 | $67 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, Sotyktu, TALTZ, ADBRY.
Industry payments across GA — which companies pay providers there.
